Jacob Harbo Andersen

500 total citations
16 papers, 280 citations indexed

About

Jacob Harbo Andersen is a scholar working on Economics and Econometrics, Infectious Diseases and Physiology. According to data from OpenAlex, Jacob Harbo Andersen has authored 16 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Infectious Diseases and 4 papers in Physiology. Recurrent topics in Jacob Harbo Andersen's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Chronic Disease Management Strategies (2 papers). Jacob Harbo Andersen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Chronic Disease Management Strategies (2 papers). Jacob Harbo Andersen collaborates with scholars based in Denmark, United States and Sweden. Jacob Harbo Andersen's co-authors include Anton Pottegård, Lotte Rasmussen, Jesper Hallas, Martin Ernst, Peter Bjødstrup Jensen, Mikkel Højlund, Rikke Wesselhöeft, Helene Kildegaard, Reimar W. Thomsen and Mette Bliddal and has published in prestigious journals such as Journal of the American Geriatrics Society, European Respiratory Journal and Acta Psychiatrica Scandinavica.

In The Last Decade

Jacob Harbo Andersen

15 papers receiving 277 citations

Peers

Jacob Harbo Andersen

SURGE

PMH

EDM

PHYSI

Susanne Engel Germany

Margherita Andretta Italy

Philip L. Cyr United States

Mikkel Zöllner Ankarfeldt Denmark

Hayley J. Dykhoff United States

Sonali N. Shah United States

Christina Rosebush United States

Magdalena Milewska Poland

Anne Utech United States

Ioanna Kouri United States

Susanne Engel Germany

Jacob Harbo Andersen

39 ×0.6

SURGE

58 ×0.9

PMH

45 ×0.9

EDM

43 ×1.0

39 ×1.0

PHYSI

Citations per year, relative to Jacob Harbo Andersen Jacob Harbo Andersen (= 1×) peers Susanne Engel

Countries citing papers authored by Jacob Harbo Andersen

Since Specialization

Citations

This map shows the geographic impact of Jacob Harbo Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Harbo Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Harbo Andersen more than expected).

Fields of papers citing papers by Jacob Harbo Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Harbo Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Harbo Andersen. The network helps show where Jacob Harbo Andersen may publish in the future.

Co-authorship network of co-authors of Jacob Harbo Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Harbo Andersen. A scholar is included among the top collaborators of Jacob Harbo Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Harbo Andersen. Jacob Harbo Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Reilev, Mette, Jacob Harbo Andersen, Mikkel Højlund, et al.. (2025). Initiation and Discontinuation of Psychotropic Drugs Relative to Suicidal Behavior: A Danish Registry‐Based Study. Acta Psychiatrica Scandinavica. 151(6). 698–708.

Rentsch, Christopher T., et al.. (2025). Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity. Journal of the American Geriatrics Society. 73(8). 2485–2493. 1 indexed citations

Pottegård, Anton, Jacob Harbo Andersen, Jens Søndergaard, et al.. (2024). Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose‐lowering therapies. Diabetes Obesity and Metabolism. 26(11). 4996–5004. 3 indexed citations

Bygum, Anette, et al.. (2024). Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use. British Journal of Clinical Pharmacology. 90(6). 1450–1462. 1 indexed citations

Pottegård, Anton, et al.. (2024). Short-term and long-term stroke risk following SARS-CoV-2 infection in relation to disease severity: a Danish national cohort study. BMJ Open. 14(7). e083171–e083171. 3 indexed citations

Reilev, Mette, Morten Olesen, Helene Kildegaard, et al.. (2022). Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptake. Scandinavian Journal of Public Health. 50(6). 686–692. 11 indexed citations

Kristensen, Kasper Bruun, Lars Christian Lund, Peter Bjødstrup Jensen, et al.. (2022). Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical Epidemiology. Volume 14. 567–579. 24 indexed citations

Højlund, Mikkel, Lárus S. Guðmundsson, Jacob Harbo Andersen, et al.. (2022). Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020. Basic & Clinical Pharmacology & Toxicology. 132(1). 60–70. 15 indexed citations

Sørensen, Anne Mette Skov, Rikke Wesselhöeft, Jacob Harbo Andersen, et al.. (2022). Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020. European Child & Adolescent Psychiatry. 32(10). 2049–2056. 13 indexed citations

10.

Madsen, Hanne, et al.. (2022). Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality. European Respiratory Journal. 60(3). 2103054–2103054. 34 indexed citations

11.

Madsen, Hanne, et al.. (2022). Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults. ERJ Open Research. 8(3). 142–2022. 3 indexed citations

12.

Kildegaard, Helene, Jacob Harbo Andersen, Peter Bjødstrup Jensen, et al.. (2022). Risk of Appendicitis After mRNA COVID-19 Vaccination in a Danish Population. JAMA Internal Medicine. 182(6). 684–684. 7 indexed citations

13.

Pottegård, Anton, Jacob Harbo Andersen, Jens Søndergaard, Reimar W. Thomsen, & Tina Vilsbøll. (2022). Changes in the use of glucose‐lowering drugs: A Danish nationwide study. Diabetes Obesity and Metabolism. 25(4). 1002–1010. 31 indexed citations

14.

Bliddal, Mette, Lotte Rasmussen, Jacob Harbo Andersen, et al.. (2022). Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults. JAMA Psychiatry. 80(2). 176–176. 44 indexed citations

15.

Højlund, Mikkel, Jacob Harbo Andersen, Kjeld Andersen, Christoph U. Correll, & Jesper Hallas. (2021). Use of antipsychotics in Denmark 1997–2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses. Epidemiology and Psychiatric Sciences. 30. e28–e28. 32 indexed citations

16.

Thompson, Wade, Lucas Morin, Dorte Ejg Jarbøl, et al.. (2021). Statin Discontinuation and Cardiovascular Events Among Older People in Denmark. JAMA Network Open. 4(12). e2136802–e2136802. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact